These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 11843841)
21. Canine idiopathic thrombocytopenic purpura. Lewis DC; Meyers KM J Vet Intern Med; 1996; 10(4):207-18. PubMed ID: 8819045 [TBL] [Abstract][Full Text] [Related]
22. [Diagnostic approach and treatment of immune thrombocytopenia in adults]. Kolonić SO; Patekar MB; Milunović V Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250 [TBL] [Abstract][Full Text] [Related]
23. Platelet Apoptosis and PAI-1 are Involved in the Pro-Coagulant State of Immune Thrombocytopaenia Patients Treated with Thrombopoietin Receptor Agonists. Justo Sanz R; Monzón Manzano E; Fernández Bello I; Teresa Álvarez Román M; Martín Salces M; Rivas Pollmar MI; Jiménez Yuste V; Butta NV Thromb Haemost; 2019 Apr; 119(4):645-659. PubMed ID: 30743272 [TBL] [Abstract][Full Text] [Related]
24. Recent advances in the management of immune thrombocytopenic purpura (ITP): A comprehensive review. Madkhali MA Medicine (Baltimore); 2024 Jan; 103(3):e36936. PubMed ID: 38241567 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia. Kurata Y; Hayashi S; Kiyoi T; Kosugi S; Kashiwagi H; Honda S; Tomiyama Y Am J Clin Pathol; 2001 May; 115(5):656-64. PubMed ID: 11345828 [TBL] [Abstract][Full Text] [Related]
26. Thrombopoietin and platelet production in chronic immune thrombocytopenia. Kuter DJ; Gernsheimer TB Hematol Oncol Clin North Am; 2009 Dec; 23(6):1193-211. PubMed ID: 19932428 [TBL] [Abstract][Full Text] [Related]
27. Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP). Gudbrandsdottir S; Ghanima W; Nielsen CH; Feng X; Hasselbalch HC; Bussel J Platelets; 2017 Jul; 28(5):478-483. PubMed ID: 27819522 [TBL] [Abstract][Full Text] [Related]
28. Current and emerging treatments for immune thrombocytopenia. Dou X; Yang R Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783 [No Abstract] [Full Text] [Related]
29. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists. Makar RS; Zhukov OS; Sahud MA; Kuter DJ Am J Hematol; 2013 Dec; 88(12):1041-4. PubMed ID: 23913253 [TBL] [Abstract][Full Text] [Related]
30. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura]. Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235 [TBL] [Abstract][Full Text] [Related]
31. The potential role of thrombopoietin in idiopathic thrombocytopenic purpura. von dem Borne A; Folman C; van den Oudenrijn S; Linthorst G; de Jong S; de Haas M Blood Rev; 2002 Mar; 16(1):57-9. PubMed ID: 11913997 [TBL] [Abstract][Full Text] [Related]
32. [Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C]. Bacq Y; Sapey T; Gruel Y; Fimbel B; Degenne D; Barin F; Metman EH Gastroenterol Clin Biol; 1996; 20(3):303-6. PubMed ID: 8763070 [TBL] [Abstract][Full Text] [Related]
33. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura. Kuter DJ Eur J Haematol Suppl; 2008 Feb; (69):9-18. PubMed ID: 18211568 [TBL] [Abstract][Full Text] [Related]
34. Tissue uptake of circulating thrombopoietin is increased in immune-mediated compared with irradiated thrombocytopenic mice. Chang M; Qian JX; Lee SM; Joubran J; Fernandez G; Nichols J; Knoppel A; Buzby JS Blood; 1999 Apr; 93(8):2515-24. PubMed ID: 10194430 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura. Kajihara M; Okazaki Y; Kato S; Ishii H; Kawakami Y; Ikeda Y; Kuwana M J Gastroenterol Hepatol; 2007 Jan; 22(1):112-8. PubMed ID: 17201890 [TBL] [Abstract][Full Text] [Related]
36. Alpha-interferon therapy induces improvement of platelet counts in children with chronic idiopathic thrombocytopenic purpura. Donato H; Kohan R; Picón A; Rovó A; Rapetti MC; Schvartzman G; Lavergne M; de Galvagni A; Rosso A; Rendo P J Pediatr Hematol Oncol; 2001 Dec; 23(9):598-603. PubMed ID: 11902304 [TBL] [Abstract][Full Text] [Related]
38. Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts. Larsen OH; Stentoft J; Radia D; Ingerslev J; Sørensen B Br J Haematol; 2013 Jan; 160(2):228-36. PubMed ID: 23151086 [TBL] [Abstract][Full Text] [Related]
39. Management of immune thrombocytopenic purpura in children: potential role of novel agents. Bredlau AL; Semple JW; Segel GB Paediatr Drugs; 2011 Aug; 13(4):213-23. PubMed ID: 21692546 [TBL] [Abstract][Full Text] [Related]
40. [A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura]. Zhao YQ; Wang QY; Zhai M; Xu J; Chen XQ; Liu WL; Zhang M; Song SJ; Wang JM; Meng FY; Shan YD Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):608-10. PubMed ID: 15355668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]